< Back to search
Filter
1
New

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

for
Non Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma,
Location: Cleveland OH
Sponsor: Paolo Caimi, MD

Sex: All

Age: 18+

Code: NCT07225439

Phase1, Recruiting
New

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

for
B-cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Nashville TN, Aurora CO, Eugene OR
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07520006

Phase1, Phase2, Recruiting
New

Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma

for
Diffuse Large B Cell Lymphoma (DLBCL)
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 70+

Code: NCT06594939

Phase2, Recruiting
New

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

for
B-cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Fairfax VA, Macon GA, Fort Wayne IN, Indianapolis IN,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07516093

Phase3, Recruiting

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

for
Non-Hodgkin Lymphoma, Multiple Myeloma, Histiocytic Neoplasms,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05093335

Early_phase1, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

for
Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndromes,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05745285

Recruiting

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

for
Leukemia, High Risk Acute Lymphoblastic Leukemia,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 25

Code: NCT06839456

Phase1, Phase2, Recruiting

Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors

for
Lymphoma, Cancer Survivors
Location: Montreal
Sponsor: McGill University

Sex: All

Age: 18 - 39

Code: NCT05257785

Recruiting

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

for
B-NHL, B-Non Hodgkin Lymphoma, Acute Lymphocytic Leukemia,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3 - 39

Code: NCT05442515

Phase1, Phase2, Recruiting

PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy

for
Non Hodgkin Lymphoma
Location: San Francisco CA
Sponsor: Michael Randall

Sex: All

Age: 18+

Code: NCT06522932

Phase1, Recruiting

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

for
Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04045470

Recruiting

Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma

for
Ann Arbor Stage II Follicular Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06442475

Phase2, Recruiting

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

for
Lymphoma, Primary Effusion
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05907759

Phase2, Recruiting

Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma

for
Marginal Zone Lymphoma
Location: Miami FL, Atlanta GA, Nashville TN, Duarte CA
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05296070

Phase2, Recruiting

CTCL Directed Therapy

for
Lymphoma, T-Cell, Cutaneous
Location: Bronx NY
Sponsor: James J. Peters Veterans Affairs Medical Center

Sex: All

Age: 30 - 70+

Code: NCT03116659

Early_phase1, Recruiting

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Recurrent Chronic Lymphocytic Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04169737

Phase2, Recruiting

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

for
Indolent B-Cell Non-Hodgkin Lymphoma,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06386315

Phase2, Recruiting

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Montreal
Sponsor: Iksuda Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT05365659

Phase1, Recruiting

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

for
Unresectable, Locally Advanced, Metastatic Cancers,
Location: Quebec, Toronto, Cleveland OH, West Valley City UT,
Sponsor: Recursion Pharmaceuticals Inc.

Sex: All

Age: 12+

Code: NCT06678659

Phase1, Phase2, Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Bethesda MD, Nashville TN, Chicago IL, Houston TX,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase1, Recruiting